EBV persistence involves strict selection of latently infected B cells

Journal of Immunology

Volumn 165, Issue 6, 2000, Pages 2975-2981

  Joseph, A M ^a   Babcock, G J ^a   Thorley Lawson, D A ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD27 ANTIGEN;

ARTICLE; B LYMPHOCYTE; CELL LINE; EPSTEIN BARR VIRUS; IMMUNOSURVEILLANCE; MEMORY CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; VIRUS INFECTION; VIRUS PATHOGENESIS;

EID: 0034665337     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.165.6.2975     Document Type: Article

References (40)

1. Epstein-Barr virus and its replication
2. Epstein-Barr virus
3. Surface markers on human B and T lymphocytes. VIII. Association between complement and Epstein-Barr virus receptors on human lymphoid cells
4. Identification and characterization of the Epstein-Barr virus receptor on human B lymphocytes and its relationship to the C3d complement receptor (CR2)
5. Epstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2
6. Epstein-Barr virus uses HLA class II as a cofactor for infection of B lymphocytes
7. Influence of Burkitt's lymphoma and primary B cells on latent gene expression by the nonimmortalizing P3J-HR-1 strain of Epstein-Barr virus
8. Epstein-Barr virus latent gene expression during the initiation of B cell immortalization
9. Identification of critical cis elements involved in mediating Epstein-Barr virus nuclear antigen 2-dependent activity of an enhancer located upstream of the viral BamHI C promoter
10. Epstein-Barr virus nuclear antigen 2 transactivates latent membrane protein LMPI
11. Epstein-Barr virus nuclear antigen 2 activates transcription of the terminal protein gene
12. Genetic analysis of immortalizing functions of Epstein-Barr virus in human B lymphocytes
13. Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation
14. Epstein-Barr virus nuclear proteins EBNA-3A and EBNA-3C are essential for B-lymphocyte growth transformation
15. A novel form of Epstein-Barr virus latency in normal B cells in vivo
16. Detection of the latent form of Epstein-Barr virus DNA in the peripheral blood of healthy individuals
17. Identification of the site of Epstein-Barr virus persistence in vivo as a resting B cell
18. Epstein-barr virus-infected resting memory B cells, not proliferating lymphoblasts, accumulate in the peripheral blood of immunosuppressed patients
19. A subpopulation of normal B cells latently infected with Epstein-Barr virus resembles Burkitt lymphoma cells in expressing EBNA-1 but not EBNA-2 or LMP1
20. Epstein-Barr virus latent gene expression in uncultured peripheral blood lymphocytes
21. Epstein-Barr virus latency in blood mononuclear cells: Analysis of viral gene transcription during primary infection and in the carrier state
22. EBV persistence in memory B cells in vivo
23. EBV - Schizophrenic but not dysfunctional
24. A model for persistent infection with Epstein-Barr virus: The stealth virus of human B cells
25. Maintenance of B-cell memory by long-lived cells generated from proliferating precursors
26. Lifespan of lymphocytes
27. Germinal centers
28. Germinal center development
29. Identification of functional human splenic memory B cells by expression of CD148 and CD27
30. + peripheral blood B cells expressing the CD27 cell surface antigen carry somatically mutated variable region genes: CD27 as a general marker for somatically mutated (memory) B cells
31. Evidence for a large compartment of IgM-expressing memory B cells in humans
32. The development and repertoire of B-1 cells (CD5 B cells)
33. CD5 expression in human B-cell populations
34. Is EBV persistence in vivo a model for B cell homeostasis?
35. Epstein-Barr virus genomes are found predominantly in IgA-positive B cells in the blood of healthy carriers
36. Five human mature B cell subsets
37. Transformation of foetal human leukocytes in vitro by filtrates of a human leukaemic cell line containing herpes-like virus
38. The changing preference of T and B cells for partners as T-dependent antibody responses develop
39. Regional specialization in the mucosal immune system: What happens in the microcompartments?
40. Regional specialization in the mucosal immune system: Primed cells do not always home along the same track